 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Regulus Therapeutics Inc. (RGLS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-14 Sale | 2019-11-15 5:37 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 833 | $0.64 | $533 | 31,546 (Direct) | View |
| 2019-11-14 Sale | 2019-11-15 5:36 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 5,838 | $0.64 | $3,736 | 243,428 (Direct) | View |
| 2019-10-01 Sale | 2019-10-02 6:50 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 2,346 | $0.6827 | $1,602 | 32,379 (Direct) | View |
| 2019-10-01 Sale | 2019-10-02 6:17 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 8,743 | $0.6827 | $5,969 | 249,266 (Direct) | View |
| 2019-08-15 Sale | 2019-08-16 4:17 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 4,375 | $0.5506 | $2,409 | 258,009 (Direct) | View |
| 2019-08-15 Sale | 2019-08-16 4:16 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 899 | $0.5506 | $495 | 34,725 (Direct) | View |
| 2019-07-01 Sale | 2019-07-02 5:42 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 5,783 | $1.311 | $7,584 | 262,384 (Direct) | View |
| 2019-07-01 Sale | 2019-07-02 5:42 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 2,225 | $1.311 | $2,918 | 35,624 (Direct) | View |
| 2019-07-01 Sale | 2019-07-02 5:41 pm | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 2,669 | $1.311 | $3,500 | 77,870 (Direct) | View |
| 2019-05-14 Sale | 2019-05-16 5:25 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 39,352 | $1.219 | $47,966 | 307,519 (Direct) | View |
| 2019-05-14 Sale | 2019-05-16 5:21 pm | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 10,000 | $1.409 | $14,089 | 90,539 (Direct) | View |
| 2019-05-14 Sale | 2019-05-16 5:21 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 6,950 | $1.41 | $9,796 | 66,259 (Direct) | View |
| 2019-05-07 Purchase(A) | 2019-05-10 10:59 am | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:08 pm | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward Director | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:07 pm | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:07 pm | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:06 pm | Regulus Therapeutics Inc. | RGLS | MOTT DAVID M 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:06 pm | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:04 pm | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:04 pm | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-10-10 Option Award | 2019-10-15 4:49 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 46,500 | $0.64 | 46,500 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:48 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | Simeonidis Simos Director | 46,500 | $0.64 | 46,500 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:47 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director | 46,500 | $0.64 | 46,500 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:46 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 46,500 | $0.64 | 46,500 (Indirect) | View |
| 2019-10-10 Option Award | 2019-10-15 4:45 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 46,500 | $0.64 | 46,500 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:44 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director | 46,500 | $0.64 | 46,500 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:43 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 1,000,000 | $0.64 | 1,000,000 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:42 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 46,500 | $0.64 | 46,500 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:41 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA CFO | 210,000 | $0.64 | 210,000 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:40 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director | 46,500 | $0.64 | 46,500 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:39 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 335,000 | $0.64 | 335,000 (Direct) | View |
| 2019-08-30 Option Award | 2019-09-03 4:49 pm | N/A 2029-08-29 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA CFO | 100,000 | $0.62 | 100,000 (Direct) | View |
| 2019-05-07 Option Award | 2019-05-21 4:46 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 370,370 | $1.08 | 1,189,872 (Direct) | View |
| 2019-05-07 Option Award | 2019-05-21 4:46 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 370,370 | $0.125 | 1,189,872 (Direct) | View |
| 2019-05-07 Option Award | 2019-05-21 4:45 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 92,889 | $1.08 | 154,223 (Indirect) | View |
| 2019-05-07 Option Award | 2019-05-21 4:45 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 92,889 | $0.125 | 154,223 (Indirect) | View |
| 2019-05-07 Option Award | 2019-05-21 4:44 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 29,630 | $1.08 | 37,849 (Direct) | View |
| 2019-05-07 Option Award | 2019-05-21 4:44 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 29,630 | $0.125 | 37,849 (Direct) | View |
| 2019-05-07 Option Award | 2019-05-21 4:42 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 33,194 | $1.08 | 64,542 (Direct) | View |
| 2019-05-07 Option Award | 2019-05-21 4:42 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 33,194 | $0.125 | 64,542 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:57 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 8,000 | $0.95 | 8,000 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:25 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 188,385 | $0 | 307,519 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:25 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 10,000 | $0.95 | 307,519 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:21 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 55,414 | $0 | 90,539 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:21 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO | 8,000 | $0.95 | 90,539 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:21 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 38,512 | $0 | 66,259 (Direct) | View |
| 2019-05-14 Option Award | 2019-05-16 5:21 pm | 2019-05-14 2029-02-04 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 7,500 | $0.95 | 66,259 (Direct) | View |
| 2019-05-07 Purchase | 2019-05-10 10:59 am | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-10 10:59 am | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:08 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward Director | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:08 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward Director | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:07 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:07 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:07 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:07 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:06 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | MOTT DAVID M 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:06 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | MOTT DAVID M 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:06 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:06 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:05 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:04 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:04 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:04 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 3,703,704 | $0.125 | 3,703,704 (Indirect) | View |
| 2019-05-07 Purchase | 2019-05-09 6:04 pm | 2019-05-07 N/A | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 256,700 | $10.8 | 3,703,704 (Indirect) | View |